| Share Name |
Share Symbol |
Market |
Type |
Share ISIN |
Share Description |
| Benchmark Holdings Plc |
LSE:BMK |
London |
Ordinary Share |
GB00BGHPT808 |
ORD 0.1P |
| |
Price Change |
% Change |
Share Price |
Shares Traded |
Last Trade |
| |
-1.00 |
-1.79% |
55.00 |
646,741 |
16:26:06 |
| Bid Price |
Offer Price |
High Price |
Low Price |
Open Price |
|
53.00
|
57.00
|
57.00 |
55.00 |
56.00 |
| Industry Sector |
Turnover (m) |
Profit (m) |
EPS - Basic |
PE Ratio |
Market Cap (m) |
|
Pharmaceuticals & Biotechnology
|
127.34
|
-73.30
|
-15.03
|
|
367
|
| Last Trade Time |
Trade Type |
Trade Size |
Trade Price |
Currency |
| 16:11:18 |
O |
1,747 |
56.00 |
GBX |
| Trade Time |
Trade Price |
Trade Size |
Trade Value |
Trade Type |
| 2020-11-23 16:11:19 | 56.00 | 1,747 | 978.32 | O |
| 2020-11-23 15:23:28 | 56.00 | 1,785 | 999.60 | O |
| 2020-11-23 11:13:50 | 56.00 | 141,100 | 79,016.00 | O |
| 2020-11-23 11:00:02 | 56.50 | 6 | 3.39 | UT |
| 2020-11-23 10:55:54 | 56.00 | 206,160 | 115,449.60 | O |
| Date | Subject |
|---|
23/11/2020
08:20 | Benchmark Daily Update: Benchmark Holdings Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker BMK. The last closing price for Benchmark was 56p.
Benchmark Holdings Plc has a 4 week average price of 48p and a 12 week average price of 43p.
The 1 year high share price is 57p while the 1 year low share price is currently 26.50p.
There are currently 667,685,612 shares in issue and the average daily traded volume is 652,338 shares. The market capitalisation of Benchmark Holdings Plc is £367,227,086.60.
|
09/9/2020
09:23 | edmonda: Management at Benchmark Holdings are doing as they promised: the disposals program is nearly complete, raising £44m which boosts financial strength. The launch of CleanTreat® + BMK08 to combat sea lice is on track.
Equity Development keeps its fair value at 63p/share, read new research note here:
https://tinyurl.com/y54mhj3a
|
23/7/2020
10:39 | 36jay: Massive update.Fire work soon.https://www.investegate.co.uk/benchmark-hlgs-plc--bmk-/rns/sale-of-vaccine-manufacturing-assets/202007231105018934T/
|
03/6/2020
15:46 | edmonda: #BMK Genetics division was resilient, ongoing restructuring and cost containment a priority, DCF valuation of BMK is £421m or 63 pence per share https://research.equitydevelopment.co.uk/research/streamlined-for-growth-and-efficiency
|
02/4/2020
15:16 | edmonda: Latest note on BMK and how they're coping with COVID-19 is here: https://equitydevelopment.co.uk/edreader/?d=%3D%3DQOwcjM
|
09/3/2020
11:32 | edmonda: after the successful raise of £43m and Q1 result, new research is out with increased sales and EBITDA forecasts.
Analyst's fair value rises to £479m, or 72p / share, with product launches and disposals to look forward to.
Click here for free access to note: https://tinyurl.com/tp22gso
|
10/1/2020
17:20 | btfd497: I debated it for a while but sold up as I wanted to free funds for Beyond Meat (BYND) which is gaining massive traction due to the vegan movement + the burgers they make are very tasty! Will keep an eye on BMK as I do think at some point it will go up v quickly.
|
10/1/2020
17:00 | murdo mcsponge: For what it's worth, I would not be selling now, and I've been in for over 2 years. I'm down circa 7p a share, but my time scale for this Company was always 3 to 5 years before it would even begin to show its true value. But good luck. I hope you don't end up regretting your move.
|
23/10/2019
17:10 | napoleon 14th: Norwegians helping OUT Woodford, & helping themselves IN?
BMK Woodford dropped below 5% from 12.45% in July and the same day Kverva Finans AS went from nothing to 11.47%
|
23/10/2019
11:40 | miss womble: What is going on here? 91 million, yes 91 million shares, sold this morning and there is no apparent change in the price. Can anybody give me an answer?
|
02/7/2019
18:45 | murdo mcsponge: The Norwegians like to think they know a lot about Aquaculture. The fact that this outfit has picked up a 10%+ interest, which when added to the other Norwegian Company's holding of,I think circa 30%, makes an impressive Norwegian interestin BMk. IMHO it bodes well for future growth in BMKK and its share price.
|
Benchmark share price data is direct from the London Stock Exchange
PLUS1
UK EXECUTIVE CHANGE SUMMARY: InnovaDerma Hires Blake Hughes As New CEO